In a mouse model of diabetes, mycophenolate mofetil attenuated diabetic nephropathy by reducing T lymphocyte infiltration in the kidneys, with an increase in IL‐17A+ CD4+ T cells observed as diabetic nephropathy progressed [22, 23]. This evidence concerns the gene IL17A and diabetes mellitus.